These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37171343)

  • 1. Prognostic value of pretreatment skeletal muscle index in pancreatic carcinoma patients: A meta-analysis.
    Yang L; Liao X; Xie Z; Li H
    Medicine (Baltimore); 2023 May; 102(19):e33663. PubMed ID: 37171343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role of pretreatment skeletal muscle index in gastric cancer patients: A meta-analysis.
    He X; Zhou S; Li H; Gou Y; Jia D
    Pathol Oncol Res; 2023; 29():1611055. PubMed ID: 37168049
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic Value of Pretreatment Skeletal Muscle Mass Index in Esophageal Cancer Patients: A Meta-Analysis.
    Yao L; Wang L; Yin Y; Che G; Yang M
    Nutr Cancer; 2022; 74(10):3592-3600. PubMed ID: 35730425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of computed tomography derived skeletal muscle mass index in lung cancer: A meta-analysis.
    Pan XL; Li HJ; Li Z; Li ZL
    World J Clin Cases; 2022 Jul; 10(20):6927-6935. PubMed ID: 36051119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of pretreatment modified Glasgow Prognostic Score in small cell lung cancer: A meta-analysis.
    Xie Y; Li H; Hu Y
    Medicine (Baltimore); 2023 Nov; 102(45):e35962. PubMed ID: 37960803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive role of pretreatment skeletal muscle mass index for long-term survival of bladder cancer patients: A meta-analysis.
    Yuan Q; Hu J; Yuan F; An J
    PLoS One; 2023; 18(6):e0288077. PubMed ID: 37390088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of pretreatment systemic immune-inflammation index in Chinese esophageal squamous cell carcinoma patients receiving radical radiotherapy: A meta-analysis.
    Zeng X; Ye L; Luo M; Zeng D; Chen Y
    Medicine (Baltimore); 2023 Jun; 102(25):e34117. PubMed ID: 37352061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prognostic Value of Pretreatment Geriatric Nutritional Risk Index in Esophageal Cancer: A Meta-Analysis.
    Yu J; Zhang W; Wang C; Hu Y
    Nutr Cancer; 2022; 74(9):3202-3210. PubMed ID: 35486420
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.
    Kim IH; Choi MH; Lee IS; Hong TH; Lee MA
    BMC Cancer; 2021 Jan; 21(1):77. PubMed ID: 33461517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of Pretreatment Geriatric Nutrition Risk Index in Lung Cancer Patients: A Meta-Analysis.
    Wang Y; Luo L; Li J; Wang Y; Che G; Xie X
    Nutr Cancer; 2022; 74(9):3164-3171. PubMed ID: 35373678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Pretreatment Glasgow Prognostic Score/Modified Glasgow Prognostic Score in Ovarian Cancer: A Systematic Review and Meta-Analysis.
    Xu S; Song L; Liu X
    Nutr Cancer; 2022; 74(6):1968-1975. PubMed ID: 34549675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of pre-treatment advanced lung cancer inflammation index in non-small cell lung cancer: a meta-analysis.
    Tang Y; Ji Y; Yang M
    Biomarkers; 2022 Jul; 27(5):441-447. PubMed ID: 35297277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between statin use and prognosis in esophageal cancer patients: A meta-analysis.
    Lv J; Chen P; Wu J; Wen Z; Zhao C
    Medicine (Baltimore); 2023 Mar; 102(12):e33359. PubMed ID: 36961185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of 18F-FDG-PET/CT parameters in patients with pancreatic carcinoma: A systematic review and meta-analysis.
    Zhu D; Wang L; Zhang H; Chen J; Wang Y; Byanju S; Liao M
    Medicine (Baltimore); 2017 Aug; 96(33):e7813. PubMed ID: 28816978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of systemic immune-inflammation index in surgical esophageal cancer patients: An updated meta-analysis.
    Li X; Zhang S; Lu J; Li C; Li N
    Front Surg; 2022; 9():922595. PubMed ID: 36090319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
    Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
    BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
    Choi Y; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
    PLoS One; 2015; 10(10):e0139749. PubMed ID: 26437072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of Pretreatment D-Dimer Level in Small-Cell Lung Cancer: A Meta-Analysis.
    Li J; Wang Y; Li J; Che G
    Technol Cancer Res Treat; 2021; 20():1533033821989822. PubMed ID: 33563114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of early changes in CT-measured body composition in patients receiving chemotherapy for unresectable pancreatic cancer.
    Salinas-Miranda E; Deniffel D; Dong X; Healy GM; Khalvati F; O'Kane GM; Knox J; Bathe OF; Baracos VE; Gallinger S; Haider MA
    Eur Radiol; 2021 Nov; 31(11):8662-8670. PubMed ID: 33934171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of YKL-40 in colorectal carcinoma patients: A meta-analysis.
    Wang J; Qi S; Zhu YB; Ding L
    World J Clin Cases; 2022 Mar; 10(7):2184-2193. PubMed ID: 35321165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.